INTRODUCTION
An exciting theme in modern biology is moving toward joint maximization of the content and context of molecular-level observations-that is, obtaining high-resolution and contentrich information about the biological system, while also maintaining this system largely or fully intact to preserve crucial contextual information. Historically, these two goals of content and context have been in opposition, since higher-resolution analyses have tended to require disassembling the system or accepting a limited field of view. But the value of obtaining and integrating information about the identity, function, and connectivity of cells in intact 3D volumes has been increasingly appreciated.
For example, one of the current challenges in neuroscience is to query molecular identity, activity level, and circuit wiring of individual cells within intact brain networks, which would require linkage of information spanning several orders of magnitude in spatial scale. Until recently, investigating the structure of neural networks in this way required sectioning for optical access and molecular labeling, followed by computer-assisted alignment and 3D reconstruction (Denk and Horstmann, 2004; Micheva and Smith, 2007; Oh et al., 2014) . Such reconstructions have been valuable, but are often laborious, limited to small volumes, and susceptible to loss of information at section boundaries, making tract-tracing and circuit-mapping particularly difficult (Wanner et al., 2015) . However, tissue-clearing techniques have emerged that, to various degrees, enable the visualization of cell morphology (and in some cases, molecular phenotype, as well as local and long-range wiring) embedded within intact neural circuits (Chung et al., 2013; Tomer et al., 2014; Yang et al., 2014; Dodt et al., 2007; Ertü rk et al., 2012; Hama et al., 2011; Kuwajima et al., 2013; Renier et al., 2014; Tomer et al., 2015; Richardson and Lichtman, 2015; Staudt et al., 2007; Susaki et al., 2014; Tainaka et al., 2014) .
To date, these technologies have chiefly focused on interrogating proteins, whether transgenically expressed or immunohistochemically detected (with the exception of single probes tested in CLARITY-based hydrogel experiments in sectioned tissue; Chung et al., 2013; Yang et al., 2014) , and many such approaches may not be compatible with accessing the wealth of biological information contained in the RNA of large intact volumes. This untapped opportunity spans untranslated species, including microRNAs (which, among other reasons for investigation, are particularly relevant to human genetically determined diseases; Esteller, 2011) , the majority of splice variants, many immediate early gene (IEG) RNAs used to infer activity of particular regions or cells during behavior (Guzowski et al., 1999; Loebrich and Nedivi, 2009) , and even the vast majority of translated gene products, due to limited antibody specificity and availability. We sought to address this challenge by developing generalizable methods for versatile and robust RNA preservation and access within transparent, intact tissue volumes.
RESULTS

Advancing Clarified Tissue Chemistry with
Carbodiimide-Based RNA Retention Many existing clearing methods rely on incubation of tissue for prolonged periods of time at temperatures of 37 C or greater (Chung et al., 2013; Tomer et al., 2014; Yang et al., 2014; Renier et al., 2014; Susaki et al., 2014; Tainaka et al., 2014) ; however, formalin is known to revert its crosslinks at elevated temperatures, and the bonds made to nucleic acids are particularly vulnerable (Masuda et al., 1999; Srinivasan et al., 2002) . Therefore, to improve retention of RNA during high-temperature tissue clearing, we sought to introduce temperature-resistant covalent linkages to RNA molecules prior to clearing by targeting functional groups on the RNA molecule for fixation to surrounding proteins or the hydrogel matrix.
We explored three tissue-chemistry strategies: EDC (1-Ethyl-3-3-dimethyl-aminopropyl carbodiimide) for linkage of the 5 0 -phosphate group to surrounding amine-containing proteins (Pena et al., 2009; Tymianski et al., 1997) ; PMPI (p-maleimidophenyl isocyanate) for linkage of the 2 0 hydroxyl group to surrounding sulfydryl-containing proteins (Shen et al., 2004) ; and DSS (disuccinimidyl suberate) for linkage of amine-containing side chains in RNA to surrounding amine-containing proteins (Mattson et al., 1993) (Figure 1A ). These crosslinks were introduced after hydrogel embedding (Chung et al., 2013) . After fixation, samples were fully cleared and RNA was extracted from each preparation. We observed that, although DSS provided no significant increase in RNA yield (potentially due to overfixation of RNA through multiple amine groups on each RNA molecule), there was markedly improved RNA yield in EDC and PMPI-fixed samples compared with control for both 1% and 4% acrylamide hydrogel compositions ( Figure 1B ). However, since PMPI doubled tissue-clearing time, while EDC only marginally increased clearing time (1 to 2 extra days in 1 mm tissue blocks), we proceeded with EDC as an RNA-fixation agent for CLARITY.
To complement these quantitative total-RNA biochemical measures with direct visualization of retained RNA within tissue, we stained tissue samples of different hydrogel compositions with acridine orange, an intercalating RNA dye. We found significantly increased RNA staining in EDC fixed samples, with EDCtreated 1% CLARITY tissue showing the best RNA labeling ( Figures 1C and 1D ). While promising, these total RNA measures did not specifically address mRNA, the population most relevant to molecular phenotyping and activity-dependent gene expression (in contrast to the more abundant rRNA, which, by virtue of tight association with proteins, could contribute disproportionately to the improvement seen with EDC). To determine if EDC improved mRNA preservation, we performed in situ hybridization with a 50 base deoxy-thymine oligonucleotide (oligo(dT)) to target the polyA tail of mature mRNA. Again, we found that 1% CLARITY with EDC samples exhibited the highest RNA signal ( Figures 1E and 1F) . Surprisingly, the 4% acrylamide hydrogel composition both with and without EDC exhibited significantly reduced RNA detection with both acridine orange staining and oligo(dT) in situ hybridization relative to 1% acrylamide conditions (as well as weaker staining in target-specific in situ hybridization; Figure S1A ). This consistent picture may reveal that the dense hydrogel network in 4% CLARITY makes mRNA targets less accessible for probe hybridization. In support of this notion, we find high concentrations (10 M) of EDC also reduced mRNA staining, whereas more modest fixation (0.1 M-1.0 M EDC) provided the most effective labeling of RNAs ( Figures 1G and 1H) .
A major motivation for RNA detection includes broad application to clinical tissue, but human samples are particularly prone to RNA degradation since pre-fixation post-mortem intervals vary, immersion-fixation crosslinks tissue more slowly than transcardial perfusion, and clinical samples are often banked for extended periods of time. We have also found that human tissue clears more slowly and, in some cases, demands higher clearing temperatures. To test if EDC could improve RNA retention in human tissue, we compared two human samples collected during temporal lobe resection, one treated with EDC and one as an untreated control (1% CLARITY hydrogel). Although both samples showed comparably strong mRNA signal prior to clearing, we found that only the EDC-treated sample exhibited detectable mRNA after clearing ( Figures 1I and 1J ). We reasoned that EDC might not only be critical for the immediate processing of CLARITY samples, but might also enable longterm storage with little RNA loss. To test this idea, we extracted and measured total RNA from rodent tissue during each stage of the clearing process. After a small loss of RNA during clearing, there was no significant loss during subsequent storage at 4 C for up to 6 months ( Figure 1K) , demonstrating a surprising level of stability (also reflected in target-specific in situ hybridization; Figure S1B ). Together, these data identify and validate a nucleic acid-tuned CLARITY chemistry with EDC.
Quantifying Diffusion of in Situ Hybridization
Components into Clarified Tissue After ensuring stable retention of RNAs, we next focused on access to target RNAs for specific labeling in transparent tissue volumes. Traditional in situ hybridization (ISH) uses labeled DNA or RNA probes, which are detected by enzyme-conjugated antibodies that catalyze the deposition of chromophores or fluorophores at the target location. Interrogation of RNA by these methods requires the penetration of each component to the target location. Since prior work had only shown detection of RNA in small volumes (100-500 mm thick; Chung et al., 2013; Yang et al., 2014) , we sought to test the ability of ISH components to diffuse into intact EDC-CLARITY tissue.
We began by characterizing the diffusion of nucleic acid probes into EDC-CLARITY tissue. We incubated tissue blocks with 50-base DIG-labeled DNA or RNA probes and visualized the diffusion profile of these probes by cutting cross-sections through the center of the tissue blocks and quantifying probe density on the newly exposed surface via antibody-based enzymatic amplification (tyramide signal amplification; TSA) (Figure 2A) . We found that DNA probes diffused significantly faster into EDC-CLARITY tissue than corresponding RNA probes ; this important effect may be due to greater nonspecific tissue binding of RNA at this temperature, hindering penetration. Strikingly (and with substantial implications for nucleic acid labeling as the potential approach of choice for transparent tissue molecular phenotyping), we consistently observed DNA (B) 1 mm mouse brain blocks were embedded in CLARITY hydrogel containing either 1% or 4% acrylamide; then either immediately processed for RNA extraction (labeled ''Not Cleared''), or instead post-fixed overnight in PMPI, DSS, EDC, or no-fix (the latter is labeled only as ''Cleared'' since the last four categories were subsequently put through the CLARITY process until visually transparent and processed for RNA extraction). There was a significant increase in RNA yield in PMPI and EDCtreated groups relative to cleared no-fix controls (***p < 0.001, one-way ANOVA, with Sidak's post hoc multiple comparisons test; n = 6 tissue blocks per group). (C) 1 mm blocks embedded in hydrogel (containing 1% or 4% acrylamide, or 4% acrylamide with no PFA) were post-fixed with EDC (+) or no fix (À) and then cleared and stained with acridine orange to visualize total RNA levels (false colored; RNA signal in pink). (I) In situ hybridization in human tissue from temporal lobe resection. Left, small samples of resection from each patient were PFA fixed and oligo(dT) hybridization was performed to confirm that mRNA was intact before clearing. The remaining tissue was immersion fixed in 1% CLARITY hydrogel (2 days), embedded, then cleared immediately (ÀEDC), or fixed in EDC overnight at 37 C prior to clearing (+EDC).
Right, mRNA was detected by oligo(dT) and DNA was stained with propidium iodide (PropI). Scale bar, 100 mm.
(J) 3D rendering of EDC fixed human temporal lobe volume (same patient as in [G]). Scale bar, 100 mm.
(K) 1 mm tissue blocks (1% hydrogel, EDC postfix) were processed for RNA extraction at various time points: uncleared (immediately after post-fixation); 1 day and 1 week (while in clearing solution); 1 month and 6 months (after clearing and stored in PBST). There is no significant loss of RNA during storage even up to 6 months at 4 C (n = 6 slices per group, n.s. paired t test). All data are means ± SD.
See also Figure S1 .
probes reaching the center of 2 mm tissue blocks within 3 hr. It should be noted that this detection method (TSA) may saturate at higher concentrations and obscure more subtle underlying concentration gradients expected to be present at 1-3 hr time points, but these diffusion rates are still considerably faster than observed for antibodies (Chung et al., 2013; Tomer et al., 2014) . At 37 C (optimized for DNA-RNA hybridization), DNA probes reached the center of a 2-mm-thick block in <1 hr ( Figure 2E ). In contrast, enzyme-linked Fab antibody fragments penetrated only $500 mm into tissue even after 2 days ( Figure 2F ). Importantly, the rate of diffusion for the Fab fragment was almost two orders of magnitude slower than that of the DNA oligonucleotide ( Figure 2G ) under the EDC-CLARITY-ISH condition. Taken together, these experiments reveal that short DNA probes rapidly diffuse throughout large volumes of EDC-CLARITY tissue and suggest that an optimal approach to labeling native RNA species in large intact volumes could leverage the speed and specificity of short DNA probes in addition to EDC tissue chemistry.
In Situ Hybridization in EDC-CLARITY Based on these findings that demonstrate stable retention of RNA with EDC-CLARITY and rapid penetration with short DNA probes, we next sought to develop a panel of oligonucleotidebased ISH techniques for application to large transparent tissue volumes. We began with digoxigenin (DIG)-labeled DNA oligonucleotide probes targeting somatostatin mRNA (three probes) and amplified with anti-DIG HRP-conjugated antibody and TSA (Figure 3A) . In initial tests, we were readily able to resolve individual cells expressing somatostatin mRNA, demonstrating that specific mRNA species within the EDC-CLARITY hydrogel can be retained and are accessible to ISH probes ( Figure 3C ).
However, using this technique in larger volumes revealed two major limitations: (1) the surface of the tissue sections showed non-specific staining that could result in false positives during cell detection, and (2) the signal was visible only to a depth of <300 mm ( Figure 3C ). A similar pattern was seen in parallel experiments with a probe set targeting YFP mRNA in a Thy1-YFP transgenic mouse, confirming that, under these conditions, TSA signal at the tissue surface lacks specificity ( Figure S2C ). (F) Antibody diffusion. CLARITY tissue is incubated in 50 base oligonucleotide probes overnight, washed, and transferred to anti-DIG antibody conjugated to HRP for time indicated. Tissue is sectioned as in (A), and antibody diffusion is detected by TSA. For 4 hr, n = 25 ROIs; 12 hr, n = 8; 24 hr, n = 17; 48 hr, n = 24. (G) Diffusion constants and R 2 values for nucleic acid and antibody diffusion in CLARITY tissue. Constants calculated by fitting average curves to Fick's Law: y = n0*erfc(x/(2*O(D*t))) for one dimensional diffusion in a uniform medium with constant boundary condition. Diffusion rate is slower than reported previously in CLARITY tissue (Li et al., 2015) , which may arise from additional crosslinking during EDC fixation, or changes in tissue properties during in situ hybridization. Curves used for fitting: RNA, 3 hr incubation; DNA, 30 min incubation; antibody, 4 hr incubation. All error bars indicate SEM. All scale bars, 100 mm.
We hypothesized that the main sources of surface staining and signal heterogeneity resulted from a concentration gradient of antibody penetrating the EDC-CLARITY hydrogel and consequently greater surface deposition of fluorophore during enzymatic amplification. We and others have found that probes can be labeled directly with fluorophore when RNA copy number is high and little amplification needed , though with limitations on sensitivity and volume size (up to 1 mm blocks, still far greater than the 20-40 mm queried with traditional techniques). Nevertheless, this restriction in volume, the need for exclusion of superficial tissue, and the severe limitation to highly expressed transcripts together pointed to the need for further innovation to exploit the speed of DNA penetration into EDC-CLARITY tissue.
DNA-Based ISH Signal Amplification
We hypothesized that an all-DNA-based amplification system rather than the traditional antibody approach might be an ideal solution. Recent work has capitalized upon the programmable base pairing of DNA molecules to design DNA structures that amplify signal by several orders of magnitude (Battich et al., 2013; Choi et al., 2010) . We explored integrating this approach with EDC-CLARITY tissue chemistry, selecting the hairpin chain reaction amplification system (HCR; Choi et al., 2010) for further development since HCR (1) involves only small DNA oligonucleotides (<150 bases), which self-assemble at the target mRNA, and (2) requires only two hybridization steps ( Figure 3B ). In the first hybridization step, an oligonucleotide probe containing a 36-base initiator sequence binds to target mRNA. In a second step, two fluorophore-tagged oligonucleotides are added, which are kinetically trapped in a hairpin conformation in the absence of the initiator sequence. As they diffuse into the tissue and encounter initiator sequences on hybridized probes, base pairing between the initiator sequences and the single-stranded toehold on Hairpin 1 open the hairpin, revealing a new initiator sequence capable of opening Hairpin 2. In turn, Hairpin 2 opens to reveal the original initiator sequence, starting the cycle anew. As the chain self-assembles, fluorophores (F) Ratio of signal to background as a function of depth in tissue, calculated from ratio of mean signal intensities segmented in (F) to the mean background intensity. For (E) and (F), No Probe, n = 3; Control Probe, n = 3; TSA, n = 5; HCR, n = 9; Sst-TFP, n = 4. p < 0.05, Kruskal-Wallis test on mean ratio over entire depth. All error bars indicate SEM. See also Figure S2 . accumulate at the target location. It is estimated that the hairpin chain reaction can amplify the signal approximately 200-fold (Choi et al., 2014) , and we expected that this degree of amplification might be sufficient to detect RNA in EDC-CLARITY.
To test this approach, we appended initiator sequences to the 3 0 and 5 0 ends of the three somatostatin oligonucleotide probes used above, hybridized the probes to EDC-CLARITY tissue, and amplified with HCR hairpins. We found that the combination of EDC-CLARITY and HCR amplification exhibited excellent signal, low background, produced no non-specific surface staining, and significantly improved the depth at which we could identify individual cells ( Figure 3D ). The signal-to-background ratio was significantly higher than in TSA-based amplification (Figure 3F) with the characteristic sparse pattern of somatostatin mRNA expression clearly distinguishable from background (Figure 3D) . Moreover, the distribution and cell density detected with HCR amplification mirrors somatostatin expression in transgenic reporter mice, underscoring the specificity of this method (Sst-TFP, Figure 3E ).
In Situ Hybridization in Intact Tissue
Linking information on cellular morphology, connectivity, and activity to information on RNA expression will be of substantial value; accordingly, we sought conditions for in situ hybridization in EDC-CLARITY that maintained fluorescence of transgenically expressed proteins. As a proof of concept, we performed in situ hybridization for YFP mRNA on Thy1-YFP transgenic mouse tissue and formulated a hybridization buffer that allowed reduction of hybridization temperature from 45 C to 37 C, which improved fluorescence in dendrites and axons while maintaining ISH specificity ( Figures 4A and S2 and Movie S1). To provide a generalizable framework for HCR-based RNA detection in EDC-CLARITY, we used these hybridization conditions to design, test, and refine sets of 50-mer DNA probes for several representative and broadly useful target RNAs for molecular phenotyping in nervous system tissue: somatostatin, parvalbumin, neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), tachykinin1, tachykinin2, tyrosine hydroxylase, and Malat1. These targets showed reliable signal in EDC-CLARITY tissue and corresponded to known anatomical distributions in both neural and non-neural tissue ( Figures 4B-4I and Figure S3 ).
In refining these probe sets, we typically performed initial testing on pools of 5-10 probes; in cases where we observed non-specific staining, we then tested probes individually to identify and discard probes contributing significantly to background, which improved image quality ( Figure S4A ). Under these conditions, we estimate that HCR in CLARITY tissue results in $50-fold amplification per double-initiator-labeled probe ( Figures  S4D-S4F ). In agreement with previous results, increasing the number of initiators, whether by adding initiators to both 5 0 and 3 0 ends or by adding more probes, enhances signal substantially (Choi et al., 2014) . This effect may eventually saturate if limited by slightly sublinear amplification ( Figures S4B and S4C) , but low copy-number transcripts may still benefit from a larger set of probes. In comparing these results to published data from single-cell transcriptomics (Zeisel et al., 2015) , we find that our data capture relative differences among gene expression levels across almost 2 orders of magnitude ( Figures S4G and S4H) ; indeed, with 4 probes per target, this approach allows detection of mRNAs present at as low as $50 copies/cell ( Figure S4H ). Although not as sensitive as RNA-seq, probe sets can be expanded as shown below, and the large volumes processed in a single CLARITY experiment enable inclusion of spatial information and sampling from many more cells than would be achieved with RNA-seq (particularly important if genes are expressed in sparse subsets within a tissue).
Since low copy-number transcripts may benefit from additional probes and since it was important to determine if our methodology could be readily adapted to diverse probe design strategies, we tested the feasibility of using a larger set of shorter probes by attaching initiators to the 5 0 end of probe sets originally designed for single-molecule fluorescent in situ hybridization (smFISH), which typically uses 20-mer oligonucleotides (30-50 probes) that tile the mRNA target sequence. As with directly fluorophore-labeled 20-mer probes, we expected that with many HCR-labeled 20-mers, the on-target signal would accumulate in cells in which many probes bind and amplify (whereas offtarget binding would be uniform across the sample); we did not, however, expect that HCR with these probes would provide single-molecule capability. Using this strategy, we were able to detect tyrosine hydroxylase, SERT, and Drd2 mRNA in EDC-CLARITY tissue, demonstrating that the HCR approach is adaptable to other probe types in CLARITY and compatible with larger pools of short probes ( Figures 4J-4L and Movies S2 and S3). Because longer nucleotides are more expensive to synthesize and purify, the strategy of using short probes would reduce overall cost and may enable significantly greater signal amplification.
Likely owing to the quick and uniform diffusion of DNA probes and hairpins, we find that tissue blocks up to at least 3 mm thick could be used for intact in situ hybridization ( Figure 4M and Movies S4 and S5). Another unique advantage of nucleic acid detection (relative to antibody-based detection) is that once the target sequence is known, it is possible to design probes for the target that are highly specific, permanently renewable, and cost effective. We therefore anticipate that this methodology for RNA detection in EDC-CLARITY may be versatile for probing a variety of transcriptional products across many tissue-types and species.
Detection of Activity-Dependent Genes and Non-coding RNAs in Intact Volumes
Many mRNAs are transiently upregulated by activity, a fact that has been instrumental in identifying cells and circuits recruited during particular behaviors (e.g., Loebrich and Nedivi, 2009 ). Using such immediate early genes (IEGs), it has been possible to identify neurons involved in complex behaviors (even multiple behaviors separated in time; Guzowski et al., 1999; Reijmers et al., 2007) , to visualize behaviorally relevant neurons in transgenic mice, in some cases long after the behavior itself (Barth et al., 2004; Guenthner et al., 2013; Smeyne et al., 1992) , and to manipulate these IEG-expressing neurons to modify or recapitulate the observed behavior (Garner et al., 2012; Liu et al., 2012; Ramirez et al., 2013 ). Yet a major unmet goal is linking form and function: to align these transcriptional activity changes with molecular phenotype and connectivity information in large intact volumes. We therefore next designed HCR probe sets against several canonical activity-regulated transcripts, Arc (Lyford et al., 1995) , c-fos (Sheng et al., 1990) , and Npas4 (Bloodgood et al., 2013) , and tested these probes in a kainic acid seizure model (known to induce robust hippocampal transcription of many activity-regulated genes; Nedivi et al., 1993) . We found that we were able to reliably track changes in expression of all of these activity-regulated genes in EDC-CLARITY. For example, Npas4 is normally expressed in scattered cells in cor- tex but is robustly transcribed in both hippocampal pyramidal cells and interneurons after seizure activity ( Figure 5A ). In parallel experiments, increases in c-Fos transcription in hilar neurons and Arc transcription in dentate granule cells were readily detectable ( Figures 5B and 5C ), as described previously in hippocampal seizure models (Lyford et al., 1995) .
Lastly, we assessed detection of smallnoncoding RNAs-a major motivation for this entire approach since these are undetectable by antibodies yet also are (1) critical for the modulation of post-transcriptional gene expression; (2) play key roles in human genetic diseases (Esteller, 2011) ; and( 3) represent a wealth of biological information not yet approached by any tissue clearing technique. Indeed, due to small size, microRNAs have fewer amines to react with paraformaldehyde or acrylamide and are easily lost from fixed tissues (Pena et al., 2009; Renwick et al., 2013) .
Consistent with this expected challenge, we found that posttreatment with EDC was critical for the retention of miRNAs in EDC-CLARITY ( Figure S5A ). Using DIG-labeled locked nucleic acid probes, we targeted several miRNAs with known function in the mammalian brain and in neuropsychiatric disease (miR- 10, miR-124, and miR-128) , as well as a miRNA known to exist only outside the mammalian brain (miR-21) to serve as a negative control (Landgraf et al., 2007) . We detected robust expression of these miRNAs in volumes of mouse brain in a pattern largely limited to areas with anticipated expression (as inferred from miRNA deep-sequencing experiments). miR-10 signal (for instance) was almost exclusively recovered in the thalamus, miR-124 was observed to be more ubiquitously present throughout the brain, and miR-128 showed characteristic forebrain and cerebellar enrichment ( Figures 5D, S5B , and S5C). We observed minimal signal for miR-21 under the same detection and amplification conditions, as expected, highlighting the specificity of the miRNA signals observed (Figures S5B and S5C) .
miR-128 is particularly well studied in the context of its known disease-relevance for oncogenic suppression (Pang et al., 2009 ) and predisposition to mood disorders (Zhou et al., 2009 ), but until now, miR-128 expression has not been visualized volumetrically in the mammalian brain at single-cell resolution, which we were readily able to achieve here ( Figure 5D ). To further test potential utility of this approach in the study of brain disease, we endeavored to detect miR-128 in human clinical samples to determine if differences in expression might be associated with human glioblastomas (suggested but not directly observed; Ciafrè et al., 2005) . We indeed were able to detect miR-128 in human GBM samples processed in EDC-CLARITY hydrogel; moreover, by integrating antibody staining (in this case, GFAP to mark tumor location) with ISH in EDC-CLARITY, we could track the crucial relative relationships of GFAP and miR-128 expression across the tissue volume at cellular resolution ( Figure 5E ). Such an approach designed to provide 3D volumetric access to miRNAs in biopsied or postmortem human brain samples may be valuable in the search for tissue-level disease insights, biomarkers, and therapeutic targets for neurological and psychiatric disease.
Multiplexed Molecular Phenotyping
Finally, we sought to develop methods for multiplexed detection of RNA in EDC-CLARITY to address the critical and rapidly growing need for multiple overlaid markers of cell identity or activity in the native anatomical context. Using multiplexed hybridization and amplification with orthogonal hairpin sets (Choi et al., 2014) , we were able to simultaneously label multiple mRNAs in EDC-CLARITY. Of note, although orthogonal hairpins were equivalent in amplification, individual fluorophores varied in fluorescence signal, as may be expected by differences in tissue autofluorescence, fluorophore efficiency, and light transmittance at different wavelengths ( Figure S6 ). Nevertheless, somatostatin, parvalbumin, and tyrosine hydroxylase could be simultaneously hybridized and amplified with sets of orthogonal hairpins carrying Alexa514, Alexa647, and Alexa546 fluorophores, respectively ( Figure 6A and Movie S5). We were also able to combine in situ hybridization for cell-type markers with in situ hybridization for activity markers ( Figure 6B ). Taken together, these data demonstrate key steps toward integrated investigation of cellular structure and typology, microRNA expression, and activity-regulated gene transcription within intact tissue volumes.
DISCUSSION
While whole-mount in situ hybridization has long been a standard technique to query RNA populations in small transparent or embryonic tissue, the scattering properties of adult tissues have prevented extension to most adult samples. Moreover, while tissue clearing methods to meet the challenge of scattering have been described for over 100 years (Spalteholz, 1911 ), along with a resurgence in interest and innovation over the past decade, visualization of RNA in large blocks of intact tissue has remained largely unaddressed (Richardson and Lichtman, 2015) despite significant advantages over protein labeling for reasons discussed above (briefly: scaling, cost, renewability, availability for all transcripts, consistency across preparations, and inclusivity of nontranslated mRNAs). Here, we report development of general methodology, tools, and resources for cellular-resolution transcriptional profiling of large and intact transparent mammalian tissue volumes, with reliable detection of diverse markers for non-coding transcripts, cell identity, and activity history.
Critically, while hydrophobic solvent-and immersion-based techniques have emerged as methods for clearing and immunostaining tissue, none have demonstrated successful RNA detection. Although these techniques might be optimized in this direction, key components could be incompatible with RNA detection. For example, in ClearT2 (an immersion-based method) the use of formamide during clearing (which is also used during hybridization to destabilize RNA duplexes) may pose challenges for probe hybridization (Kuwajima et al., 2013) . Likewise, ScaleA2, ScaleU2, ScaleS, and CUBIC use urea (Hama et al., 2011; Susaki et al., 2014; Tainaka et al., 2014) , also a destabilizing agent for hybridization (Simard et al., 2001) . Finally, hydrophobic solvent-based clearing methods (such as the 3DISCO and iDISCO techniques; Ertü rk et al., 2012; Renier et al., 2014) crosslink tissue with methanol prior to solvent clearing, which may limit access to RNA for hybridization in large volumes, and indeed, RNA labeling has not yet been shown in any of these volumetric methods. Since the specificity of nucleic acid probe hybridization requires maintenance of specific concentrations of salt and organic solvent (such as formamide) in a window that favors probe hybridization to target but not off-target RNA, aqueous-based CLARITY/hydrogel approaches appear to provide unique RNA detection advantages for compatibility with commonly used hybridization reagents.
Almost all in situ hybridization techniques for fixed tissue require permeabilization prior to hybridization to enable access of probes to target RNA (Wilkinson, 1999) . Intrinsic to the CLARITY process is permeabilization of tissue via removal of lipid membranes and denaturation of proteins, enabling RNA access without necessity of proteases (though proteases may be used as well in some forms of CLARITY). Without stabilization via cross-linking, RNA is susceptible to rapid degradation by endogenous RNases; in EDC-CLARITY, RNA is stabilized by both PFA cross-linking (which fixes RNA and renders RNases immobile) and EDC. Together, these properties may make EDC-CLARITY particularly suitable for RNA detection; nevertheless, the methodologies we describe might also be suitable for hybrid approaches to volumetric RNA detection in other clearing methods, given sufficient optimization of fixation and permeabilization parameters.
We have presented validation for select microRNAs, cell-type markers, and immediate-early genes, but with the RNA landscape preserved via EDC fixation, we anticipate that this method could be extended to additional RNA species. Oligonucleotide or LNA probes could be designed for splice junctions to visualize brain-wide expression of particular mRNA variants. Because CLARITY tissue maintains subcellular structures, this method also dovetails with catFISH approaches, where nuclear localization (or intronic or exonic targeting probes) could be used to temporally differentiate two activity-triggered transcriptional events (Guzowski et al., 1999; Lin et al., 2011) . The ability in EDC-CLARITY to use a variety of different probe types (50-mer oligos, 20-mer oligos, LNAs) and amplification methods (HCR for multiplexing and larger volumes, TSA for smaller volumes) suggests versatility, but as always, in situ hybridization must be further tailored to RNA target type, volume size, copy number, transcript length, and species.
The ability to monitor many transcripts simultaneously will be of growing relevance as the field moves toward increasingly rich and detailed molecular phenotyping. For HCR amplification, there are currently five validated hairpin sets allowing up to five targets to be labeled simultaneously (Choi et al., 2014) , but spectral separation will be a limiting factor in expanding these further. The sharp emission spectra of quantum dots could address this problem, though the effect of steric hindrance on hairpin assembly and diffusion of oligonucleotides will require testing. Opportunities associated with multi-feature typology extend beyond multiple molecular features, and include fusing molecular and anatomical datasets. Whereas typical in situ protocols degrade fluorescence, the approach shown here is compatible with maintained fluorescence of genetically encoded cell-filling proteins for visualization of 3D neuronal morphology and wiring (and thus allows integration of information about molecular identity and functional history with information on local and global connectivity across intact nervous systems).
The goal of identifying low-copy-number transcripts can be approached from several angles. During amplification, initiators could be concatenated or combined with a branched DNA approach (Battich et al., 2013) to incorporate more initiator sequences onto each probe. Additional fluorophores, or photobleach-resistant quantum dots, could be conjugated to hairpins to improve signal (Resch-Genger et al., 2008) . During hybridization, we have demonstrated that 20-mer probes could be used to tile the entire sequence with initiators, which would be particularly effective in improving detection for rare, but long transcripts. Alternatively, one could directly reverse-transcribe mRNA and amplify the resulting cDNA in situ (successful for in situ sequencing strategies), though hydrogel properties may require optimization for best enzymatic activity and diffusion of key components (Ke et al., 2013; Lee et al., 2014) .
Having characterized in EDC-CLARITY an array of probe sets for canonical markers of cell identity and activity, to facilitate the community's further benefit from (and engagement with) this growing effort of probe testing and publication, we have established a database of validated probes, with sequences and hybridization conditions available as an open online resource (http://clarityresourcecenter.org, http://wiki.claritytechniques. org/index.php/ISH). Requiring little specialized equipment, low startup costs, and moderate operational costs, this approach could provide an alternative to immunohistochemistry when specific antibodies are lacking or to traditional in situ hybridization and serial sectioning when streamlined data acquisition is needed, as with large cohorts or large tissue volumes. While each step will benefit from further innovation and optimization, flexible design of EDC-CLARITY methodologies may favor adoption across a broad application domain, from clinical samples to integrative basic analysis of structure-function properties spanning cell typology, activity in behavior, and local and global tissue relationships.
EXPERIMENTAL PROCEDURES
CLARITY Tissue Preparation CLARITY tissue was prepared as described in Tomer et al. (2014) . For A4P0 samples, tissues were prepared as described in Yang et al. (2014) . Tissue was incubated with RNA fixatives after acrylamide polymerization (EDC, 0.1 M; PMPI, 0.1 M; or DSS, 0.1 M, overnight at 37 C). Tissue was cleared passively in a 4% SDS/ 0.2 M Boric acid (pH = 8.5) clearing solution at 37 C until transparent and stored in 13 PBS with 0.3% TX-100 (PBST) at 4 C.
Total RNA Isolation and Acridine Orange Staining Cleared tissue was homogenized in 20 mg/ml proteinase K and extracted with Trizol and then acidic phenol:chloroform:isoamyl alcohol before precipitation with ethanol. For acridine orange staining, sections were rinsed in sodium citrate (SC) buffer for 10 min, incubated in acridine orange solution (100 mg/ml) for 3 hr, then rinsed in SC buffer and then PBS, and transferred to refractive index matching in FocusClear.
Probe Design
Riboprobes were generated from cDNA templates, reverse transcribed with DIG-labeled dNTPs (Roche), and purified. smFISH probes were designed and synthesized by BioSearch. DNA 50-mer oligonucleotide probes were purchased from Molecular Instruments (Caltech) or designed using OligoWiz software (Wernersson et al., 2007) and synthesized by Integrated DNA Technologies. LNA probes were synthesized by Exiqon.
Probe and Antibody Diffusion
For RNA and DNA probe diffusion, cleared tissue (2 mm) was incubated in hybridization solution for the time indicated, then cooled to 4 C, fixed with PFA, and re-sectioned (200 mm). Cross-sections of the center of tissue were selected for staining with anti-DIG antibody conjugated to HRP and detected with TSA. For antibody diffusion, tissue was incubated in 50-mer DIG-labeled oligonucleotides overnight in 40% formamide and 23SSC, cooled to 4 C, and fixed in 4% PFA for 1 hr at RT. The tissue was then incubated with anti-DIG Fab fragment antibody coupled to HRP (1:500) in PBST for the corresponding time and further processed as above for re-sectioning and TSA amplification.
In Situ Hybridization
For all in situ hybridizations, cleared tissue was equilibrated in hybridization solution for 1 hr and hybridized in the same solution overnight at 37 C unless otherwise noted, and then stringency washes were performed at the hybridization temperature to remove excess or non-specifically bound probe. Solutions and temperatures varied for each probe type and are as follows. Oligo(dT): hybridization with 15% formamide, 2xSSC, 10% dextran sulfate, 50 nM probe; stringency 33 1 hr in 15% formamide, 23SSC then 23 1 hr in 23SSC. DIG-labeled 50-mers: hybridization with 50% formamide, 53SSC, 0.5 mg/ml yeast tRNA; stringency 33 1 hr in 50% formamide, 53SSC plus 23 1 hr in 23SSC and then transferred to PBST. Initiator-labeled 50-mers: hybridization with 40% formamide, 23SSC, 10% dextran sulfate, 0.5 mg/ml yeast tRNA; stringency 331 hr in 40% formamide, 23SSC plus 231 hr in 23SSC. DNA 20-mers (smFISH sets): hybridization with 10% formamide, 23SSC, 10% dextran sulfate; stringency 331 hr in 10% formamide, 23SSC plus 231 hr in 23SSC. LNA probes: hybridization with 50% formamide, 53SSC, 0.5 mg/ml yeast tRNA, 12.5 nM DIG-labeled probe at 20 C below Tm; stringency 231 hr in 53SSC plus 1 hr in 23SSC at the same temperature. For DIG-labeled probes, tissue was washed in PBST after stringency. Tissue was incubated overnight in anti-DIG antibody conjugated to HRP (1:500) for 2 days per mm tissue thickness, washed overnight in PBST, developed with tyramide signal amplification (1:50 dilution, 30 min), washed 33 in PBST, and transferred to FocusClear for imaging. For initiator probes, tissue was equilibrated in amplification buffer (53SSC, 0.1% Tween20, 10% dextran sulfate). DNA hairpins were separately heated to 90 C, cooled to RT, and added to amplification buffer. Tissue was incubated in hairpins overnight at RT, then washed 53 1 hr with 53SSC plus 0.1% Tween20, and transferred to FocusClear for imaging. Propidium iodine staining, where applicable, was performed using a PropI/ RNase solution after stringency washes. Sections were transferred to FocusClear for 4 hr prior to imaging. Tissue shrinks once equilibrated to FocusClear for imaging; all scale bars represent the imaged volume, which is $50% of original tissue volume.
Human Tissue
Human tissue is putative healthy tissue obtained from temporal lobe resections from two patients (46-year-old female, 18-year-old male). Tissue was equilibrated in 1% hydrogel solution for 2 days at 4 C, polymerized for 5 hr at 37 C, and cleared for 5 weeks in 4% SDS at 37 C.
Confocal Microscopy
All images were taken on a Leica SP5 confocal microscope with a 103/0.4 objective (WD: 2.2 mm) or 203/0.75 objective (WD: 0.66 mm) at 488 nm (FITC), 514 nm, 543 nm, or 647 nm excitation.
Experimental Subjects
Animal husbandry and all aspects of animal care and euthanasia as described were in accordance with guidelines from the NIH and have been approved by members of the Stanford Institutional Animal Care and Use Committee. Use of surgical and post-mortem human tissue was in accordance with guidelines from the NIH and approved by the Stanford Institutional Review Board. 
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